Indication

Gastrointestinal candidiasis

Gastrointestinal candidiasis is an opportunistic fungal infection of the digestive tract, most commonly caused by *Candida albicans* or other *Candida* species that typically reside as benign commensal organisms in the human mycobiome. Read more about Gastrointestinal candidiasis

24 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Gastrointestinal candidiasis therapies.

Showing 10–18 of 24 drugs

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
LEHIGH VALLEY T

NYSTATIN

ORAL CANDIDIASIS·+2
HI-TECH/AKORN

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
MCKESSON PACKAG

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
ATLANTIC BIOLOG

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
AVKARE

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
CHARTWELL RX LL

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS·ORAL CANDIDIASIS·+2
AHP
Filter & compare in the drug finder →Opens the drug finder with Gastrointestinal candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gastrointestinal candidiasis.

Gastrointestinal candidiasis is an opportunistic fungal infection of the digestive tract, most commonly caused by *Candida albicans* or other *Candida* species that typically reside as benign commensal organisms in the human mycobiome.

The condition primarily affects individuals with compromised immune systems, altered gut microbiota, mucosal barrier disruptions, or prolonged exposure to broad-spectrum antibiotics and immunosuppressive therapies.

Pathophysiologically, it involves the transition of *Candida* from a commensal blastospore to an invasive hyphal form, leading to tissue penetration, mucosal inflammation, pseudomembrane formation, ulceration, or erosion anywhere from the esophagus to the lower bowel.

Depending on the specific segment involved, patients may present with dysphagia, odynophagia, epigastric pain, nausea, gastrointestinal bleeding, or diarrhea, with severe cases carrying a risk of transmural perforation or systemic dissemination.

Personalize your experience

Follow Gastrointestinal candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it